SECTOR : Biotech
ENTRY DATE : 2010
BUSINESS : Venture Capital
WEB : www.poxelpharma.com

Poxel

Development of innovative drugs for metabolic diseases, including type-2 Diabetes and non-alcoholic steatohepatitis

Poxel is a French listed company developing innovative drugs for a range of metabolic diseases. Founded in 2009, Poxel focuses its activities on the development of treatment for type-2 diabetes and non-alcoholic steatohepatitis.